Guoxin Health's earnings briefing draws 139 institutions for research, with 20 attendees from China Southern Fund

中国基金报··CN·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Guoxin Health held its earnings briefing by conference call on September 22, with a total of 139 institutions participating in research, making it the only A-share company this week to be surveyed by more than 100 institutions. Wind data shows that 427 A-share listed companies were surveyed by institutions this week, with Guojin Precision and Xinghui Holdings each surveyed by more than 40 institutions, and Sifangda and Espressif Systems by more than 30. Institutions attending Guoxin Health's briefing included E Fund, China Asset Management, China Southern Fund, Ruiyuan Fund, Gaoyi Asset Management, and Juming Investment, among which China Southern Fund had 20 attendees, including multiple fund managers. The company said that health service revenue grew rapidly in the first half of the year, mainly driven by the continued advancement of chronic disease management and health management businesses, with chronic disease management in Shandong continuing to progress. The company stated that over the past five years, fourth-quarter revenue has accounted for an average of 52.6% of annual revenue, and it will consolidate its traditional business base while accelerating the implementation of innovative businesses to drive sustained improvement in non-recurring net profit. In the first half of 2026, Guoxin Health's revenue was 102 million yuan, up 6.3% year on year; net loss attributable to the parent was 102 million yuan, narrowing by 3.21% year on year. The stock price has fallen 23.87% this year, with a latest total market value of 6.62 billion yuan.

Impact on assets 6

Others▲

Off-coverage companies 5

China Southern Asset Management Co., Ltd.i
Private± Mixedrelevance

E Fund Management Co., Ltd.i
Private± Mixedrelevance

睿远基金i
Private± Mixedrelevance

聚鸣投资i
Private± Mixedrelevance

高毅资产i
Private± Mixedrelevance